Researchers study drug for Alzheimer's stem cell treatment

04/24/2006 | United Press International

U.S. researchers say Axonyx's Posiphen was found to improve the ability of transplanted human neuronal stem cells to change into neurons in biotech mice. They say the Phase I trial drug appears to suppress the amyloid precursor protein, allowing new neurons to be produced in the brain, a critical development toward a stem cell therapy for Alzheimer's.

View Full Article in:

United Press International

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA
Assistant General Counsel, Regulatorya
Cardinal Health
Waukegan, IL
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA